On this page, we highlight information of partcular relevance for media, including news, events and featured information for journalists with a professional interest in the development and availability of medicines in the European Union. For more information and details relevant for media, see our News & events section. For enquiries from media, please contact the EMA press office.
EMA 2017 annual report
EMA has published its 2017 annual report, which provides an overview of the work of the Agency together with the European medicines regulatory network. It highlights last year’s major achievements in protecting and promoting public and animal health in the European Union and contains key figures on the Agency’s regulatory procedures and activities.
News and press releases
Search and filter our news and press releases.
Find out more about EMA's scientific committees and working parties
Read more about the work of EMA's committees and working parties and find information on their meeting, including agendas and outcomes.
Funding, statistics and key operating information
You can find out more on how we work including statistics and information on financial management.
News for media
Management Board re-elects Christa Wirthumer-Hoche as chair
EMA’s Management Board today re-elected Christa Wirthumer-Hoche as its chair for a three-year mandate. Dr Wirthumer-Hoche is Head of the Austrian Medicines and Medical Devices Agency , a post she has held since October 2013. This is her second and...
Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
EMA is advising healthcare professionals and patients not to exceed the recommended dose of Xeljanz (tofacitinib) when treating rheumatoid arthritis. The advice follows early results from an ongoing study (study A3921133) in patients with rheumatoid...
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 12-15 March 2019
PRAC starts review on screening patients before treatment with fluorouracil, capecitabine, tegafur and flucytosine to decrease the risk of side effects EMA’s safety committee (PRAC) has started a review of medicines containing fluorouracil (also...
EMA now operating from Amsterdam
As of today, EMA is operating from Amsterdam. EMA left its London premises on 1 March, and following a transitional week of teleworking, its staff will gradually move throughout this week into the Spark building in Amsterdam Sloterdijk. The Agency...
Regulatory information – adjusted fees for applications to EMA from 1 April 2019
The European Medicines Agency (EMA) reminds applicants and marketing authorisation holders that adjusted fees for all applications, except for pharmacovigilance procedures, will be coming into effect on 1 April 2019. Every year, the European...
New add-on treatment to insulin for treatment of certain patients with type 1 diabetes
EMA’s human medicines committee (CHMP) has adopted a positive opinion for Zynquista (sotagliflozin) intended as an adjunct to insulin for certain patients with type 1 diabetes mellitus. Zynquista is a small molecule with dual inhibitor activity on...
Events of interest
List itemFri 23 Mar23/03/2018 - 23/03/2018
European Union International Organization for Standardization (ISO) for the identification of medicinal products (IDMP) / Substance, product, organisation and referential data (SPOR) task force meeting
The EU ISO IDMP / SPOR data task force is meeting representatives from EMA, national competent...
List itemFri 18 May18/05/2018 - 18/05/2018
Third industry stakeholder platform on research and development support
This third meeting between regulators and representatives of industry stakeholder organisations...
List itemThu 07 Jun07/06/2018 - 07/06/2018
2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)
Enpr-EMA will hold its tenth annual workshop on 7-8 June 2018 at EMA. The workshop brings relevant...
List itemFri 08 Jun08/06/2018 - 08/06/2018
European network of paediatric research at the European Medicines Agency (Enpr-EMA) Coordinating Group and networks meeting
The 2018 face-to-face meeting of Enpr-EMA networks and coordinating members takes place after the...